NXTC
NextCure Inc
NASDAQ: NXTC · HEALTHCARE · BIOTECHNOLOGY
$9.21
+3.02% today
Updated 2026-04-30
Market cap
$34.70M
P/E ratio
—
P/S ratio
9.52x
EPS (TTM)
$-19.65
Dividend yield
—
52W range
$4 – $16
Volume
0.1M
NextCure Inc (NXTC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-12.51M | $7.99M | $-35.62M | $-44.95M | $-57.24M | $-53.89M | $-52.97M | $-40.80M | $-49.61M |
| Capital expenditures | $8.65M | $3.06M | $3.37M | $7.13M | $2.36M | $2.12M | $820000.00 | $474000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $75000.00 | $263000.00 | $1.89M | $7.91M | $10.29M | $9.51M | $8.19M | $6.33M | $2.99M |
| Free cash flow | $-21.17M | $4.93M | $-38.99M | $-52.09M | $-59.60M | $-56.00M | $-53.79M | $-41.28M | $-49.61M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-2.85M | $-23.91M | $14.29M | — | — | — |